HeyJaredThe Microdose
An independent journalism newsletter supported by the U.C. Berkeley Center for the Science of Psychedelics
- Indexed issues, last 90 days
- 15
- Latest publication
- Sep 25, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 27, 2026
Latest issues
Federal drug enforcement revives proposal to place five hallucinogens in Schedule I category; Oregon reverses planned fee increase for psilocybin licensees (opens the original)
Read excerpt
<img alt="" class="sizing-normal" height="1028" src="https://substackcdn.com/image/fetch/$s_!dgJR!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F653b74ee-fd2f-4aa1-aef7-d237f2a9dc5d_1667x1028.p
Did psychedelics help build ancient civilizations?: 5 Questions for journalist Andrew Lawler (opens the original)
Read excerpt
<img alt="" class="sizing-normal" height="1038" src="https://substackcdn.com/image/fetch/$s_!CL_Y!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F522ba73d-720f-4da5-a89c-e644c0d33097_3121x2225.p
Definium trial suggests LSD could help treat anxiety; “One patient meets God. The other gets itchy.”; and Compass funds psilocybin-assisted therapist training (opens the original)
Read excerpt
<img alt="" class="sizing-normal" height="1038" src="https://substackcdn.com/image/fetch/$s_!EP6w!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F36b8f912-ffe4-48d4-842b-24ee25a84a24_4680x3337.p
Report from the FDA’s hearing on psychedelic drugs (opens the original)
Read excerpt
We’re bringing you the highlights from today’s four hour-long hearing, held by the U.S. Food and Drug Administration, to solicit public comment on what the agency should consider regarding “the potential future therapeutic use” of psychedelics in regulated settings.The hearing follows a federal push that began when President Donald Trump issued an April Executive Order, aimed at accelerating access to psychedelic treatments. A <a
Psilocybin may help prevent chemo-induced nerve pain; Definium scores second FDA Breakthrough Therapy designation (opens the original)
Read excerpt
<img alt="" class="sizing-normal" height="1024" src="https://substackcdn.com/image/fetch/$s_!YL5t!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc6e9b9da-b4a9-450c-a961-998b69255650_1668x1024.p
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.